Significance of apical cavity obliteration in apical hypertrophic cardiomyopathy

Objective Apical hypertrophic cardiomyopathy (HCM) is characterised by apical systolic obliteration and is associated with atrial fibrillation (AF), stroke, heart failure (HF), and mortality. We investigated whether apical obliteration of the left ventricular (LV) cavity could have an unfavourable impact on the clinical course of apical HCM. Methods 188 patients with apical HCM (114 males, median age 67 years) were identified retrospectively from January 2008 to December 2010. The rate of apical obliteration was defined as the net obliteration to end-diastolic apical cap thickness, and the ratio of obliteration to cavity was defined as the end-systolic obliteration to cavity height. Events were defined as a composite of new onset of AF, stroke, HF, and cardiovascular (CV) death. Results There were 43 clinical events (19 AFs, 11 HFs, 9 strokes, and 4 deaths) during a follow-up of median 4.4 years. The events patients were older, had larger left atrial volume index (LAVI), lower late diastolic mitral annular tissue Doppler velocity (a′), and higher LV end-diastolic pressure (E/e′). They had greater apical thickness and obliteration, smaller systolic cavity height, higher rate of obliteration, and higher ratio of obliteration to cavity; events were significantly higher (54%) in the upper tertiles of the ratio of obliteration to cavity. Age, E/e′, a′, LAVI, apical thickness, rate of obliteration, and ratio of obliteration to cavity were associated with events. On multivariable analysis, the ratio of obliteration to cavity remained a significant predictor. Conclusions The ratio of obliteration to cavity could provide useful information to predict the occurrence of adverse events in apical HCM.

[1]  A. Briasoulis,et al.  Myocardial fibrosis on cardiac magnetic resonance and cardiac outcomes in hypertrophic cardiomyopathy: a meta-analysis , 2015, Heart.

[2]  B. Maron,et al.  New perspectives on the prevalence of hypertrophic cardiomyopathy. , 2015, Journal of the American College of Cardiology.

[3]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[4]  P. Sparrow,et al.  Cardiac Magnetic Resonance Imaging Findings Predict Major Adverse Events in Apical Hypertrophic Cardiomyopathy , 2014, Journal of thoracic imaging.

[5]  K. Kario,et al.  Clinical significance of left ventricular apical aneurysms in hypertrophic cardiomyopathy patients: the role of diagnostic electrocardiography. , 2014, Journal of cardiology.

[6]  Barry J Maron,et al.  Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. , 2014, Journal of the American College of Cardiology.

[7]  P. Elliott,et al.  Abnormal Cardiac Formation in Hypertrophic Cardiomyopathy: Fractal Analysis of Trabeculae and Preclinical Gene Expression , 2014, Circulation. Cardiovascular genetics.

[8]  Michael A. Burke,et al.  Prognostic Importance of Pathophysiologic Markers in Patients With Heart Failure and Preserved Ejection Fraction , 2014, Circulation. Heart failure.

[9]  S. Ommen,et al.  Risk of death in long-term follow-up of patients with apical hypertrophic cardiomyopathy. , 2013, The American journal of cardiology.

[10]  J. Hoffmann,et al.  Value of cardiovascular MR in diagnosing left ventricular non-compaction cardiomyopathy and in discriminating between other cardiomyopathies , 2012, European Radiology.

[11]  Y. Sung,et al.  Apical Hypertrophic Cardiomyopathy: Correlations Between Echocardiographic Parameters, Angiographic Left Ventricular Morphology, and Clinical Outcomes , 2011, Clinical cardiology.

[12]  H. Rakowski,et al.  Hypertrophy pattern and regional myocardial mechanics are related in septal and apical hypertrophic cardiomyopathy. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[13]  Gilbert Habib,et al.  Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. , 2010, European heart journal.

[14]  T. Kubo,et al.  Clinical profiles of hypertrophic cardiomyopathy with apical phenotype--comparison of pure-apical form and distal-dominant form. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[15]  T. Kubo,et al.  Clinical impact of atrial fibrillation in patients with hypertrophic cardiomyopathy. Results from Kochi RYOMA Study. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[16]  W. Manning,et al.  Response to Letter Regarding Article, “Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy” , 2009 .

[17]  Milind Y Desai,et al.  Impact of left ventricular volume/mass ratio on diastolic function. , 2009, European heart journal.

[18]  D. Kass,et al.  Cardiac Structure and Ventricular–Vascular Function in Persons With Heart Failure and Preserved Ejection Fraction From Olmsted County, Minnesota , 2007, Circulation.

[19]  B. Maron,et al.  Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States. , 2003, The American journal of cardiology.

[20]  T. Kuribayashi,et al.  Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. , 2003, Journal of the American College of Cardiology.

[21]  M. Eriksson,et al.  Long-term outcome in patients with apical hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[22]  M. Chiariello,et al.  Influence of left ventricular cavity size on clinical presentation in hypertrophic cardiomyopathy. , 1999, The American journal of cardiology.

[23]  C. Lau,et al.  Clinical characteristics of and long-term outcome in Chinese patients with hypertrophic cardiomyopathy. , 2004, The American journal of medicine.